GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6)
Authors:
- Giuseppe CampagnaGCGiuseppe Campagna
- Raffaella BuzzettiRBRaffaella Buzzetti
- for the NIRAD Study GroupFGfor the NIRAD Study Group
Open Access
- 1 October 2012
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (10) , 3759-3765
Abstract
Context: Latent autoimmune diabetes in adults (LADA) includes a heterogeneous population wherein, based on glutamic acid decarboxylase antibody (GADA) titer, different subgroups of subjects can be identified. Objective: The aim of the present study was to evaluate GADA titer-related risk for β-cell and other organ-specific autoimmunity in LADA subjects. Methods: Adult-onset autoimmune diabetes subjects (n = 236) and type 2 diabetes (T2DM) subjects (n = 450) were characterized for protein tyrosine phosphatase (IA-2IC and IA-2256–760), zinc transporter 8 (ZnT8), thyroid peroxidase, (TPO), steroid 21-hydroxylase (21-OH), tissue transglutaminase (tTG), and antiparietal cell (APC) antibodies. Results: High GADA titer compared to low GADA titer showed a significantly higher prevalence of IA-2IC, IA-2256–760, ZnT8, TPO, and APC antibodies (P ≤ 0.04 for all comparison). 21-OH antibodies were detected in 3.4% of high GADA titer. A significant decreasing trend was observed from high GADA to low GADA and to T2DM subjects for IA-2256–760, ZnT8, TPO, tTG, and APC antibodies (P for trend ≤0.001). TPO was the only antibody showing a different prevalence between gender; low GADA titer and T2DM female patients had a higher frequency of TPO antibody compared to males (P = 0.0004 and P = 0.0006, respectively), where the presence of high GADA titer conferred an odds ratio of 8.6 for TPO compared to low GADA titer. After subdividing high and low GADA titer subjects according to the number of antibodies, we observed that 73.3% of high GADA titer subjects were positive for at least one or more antibodies, compared to 38.3% of low GADA titer (P < 0.0001). Conclusions: In LADA subjects, high GADA titer was associated with a profile of more severe autoimmunity and, in male gender, specifically predisposed to thyroid autoimmunity. A regular screening for other antibodies is recommended in LADA patients according to GADA titer and gender.Keywords
This publication has 30 references indexed in Scilit:
- High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adultsClinical Endocrinology, 2011
- Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adultsEuropean Journal of Endocrinology, 2010
- The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitusDiabetic Medicine, 2008
- GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77Diabetologia, 2007
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- Diabetes-related antibodies in adult diabetic patientsBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- Type 1 Diabetes Islet Autoantibody MarkersDiabetes Technology & Therapeutics, 2002
- Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodiesClinical Endocrinology, 2000
- Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.Diabetes, 1999
- HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin‐dependent diabetes mellitusClinical Endocrinology, 1996